Construction Business Review Conferences
The American Medical Device Summit has a rich history as an exclusive platform for MedTech leaders. Now entering its 13th year, it continues to be one of the top medical device events for executives and solution providers to connect, benchmark, and explore what’s next in MedTech.
CDMO Live Americas is where external manufacturing partnerships are made.CDMO Live Americas is the award-winning event where the people who lead development and manufacturing come to find the right partners, connect with peers, and leave with a more resilient outsourcing strategy.Powered by PartnerMatch and carefully designed so the right people find each other and have the conversations that move things forward. The outsourcing community meets in Boston Back Bay, October 20–21 2026.
17th World ADC San Diego is THE one-stop bioconjugate shop bringing together the global ADC community for an unparalleled amalgamation of case studies, development trends and impactful networking opportunities to forge ADC innovation into differentiated, early-line patient outcomes. With 7 streams of end-to-end ADC content across Discovery Chemistry, Discovery Biology, Preclinical, Translational Medicine, Clinical Lessons, Process & Analytical Development, and Manufacturing & Supply Stream, all the ADC innovation will be in the spotlight for an unmissable week of data and insights to de‑risk future ADC development and push ADCs into earlier‑line oncology treatments.
The 16th World Clinical Biomarkers & Companion Diagnostics Summit is the industry’s leading global forum dedicated to advancing precision medicine through biomarker, IVD and diagnostic innovation. Returning to Boston, we will unite 850+ senior leaders from biopharma, diagnostics, regulatory bodies, healthcare organizations, and testing laboratories. Join us in accessing the latest developments in biomarker discovery, companion diagnostics, liquid biopsy, multi-omics, digital pathology, AI-driven diagnostics, and regulatory strategies.
LEAP HR: Life Sciences East is the definitive end-to-end meeting for the entire biopharma people community. This year we’ve broken down silos and for the first time, LEAP TA and LEAP TD: Life Sciences have been incorporated into a special expanded edition of LEAP HR: Life Sciences, bringing together senior Human Resources, Talent Acquisition, and Learning & Development leaders under one roof. With dedicated tracks and specialized content for each function, this is the only forum that HR, TA, and L&D leaders in life sciences need to succeed through 2026 and beyond
The 2026 edition of the Microbiome R&D and Business Collaboration Forum marks a clear shift in the field—from reactive healthcare toward proactive, longevity-driven science. As the global focus moves beyond treating disease to extending healthspan, the microbiome is emerging as a central regulator of aging biology. This year’s meeting explores how microbial ecosystems influence the biological clock, shaping everything from cognitive function and metabolic resilience to immune regulation across the lifespan. Bringing together leading academics, clinicians, and industry innovators, the forum provides a focused environment to examine both the underlying science and the pathways to real-world application.
The 7 th Genome Editing Therapeutics Summit is the only industry-focused meeting dedicated to advancing CRISPR and next-generation genome editing into the clinic, covering delivery, safety, and regulatory strategy alongside top pharma and biotech leaders.
The Evolution Summit returns September 28-29, 2026 at Park Hyatt Aviara Resort, Golf Club & Spa, San Diego, CA, bringing together leading clinical trial executives with innovative suppliers and solution providers in an invitation-only, premium setting. Expect visionary keynotes, real-world case studies, and interactive forums aligned to the most pressing challenges in clinical operations and drug development. Featured leaders include Sarah Hamirani (Portfolio Director, AbbVie) and Angela DeLuca (AVP, Global Study Operations, Amgen), alongside senior voices from AstraZeneca, Johnson & Johnson Innovative Medicine, Pfizer, Gilead Sciences, and more. Join the conversation shaping the future of clinical research.
The 8th Exosome-Based Therapeutics Summit is the premier forum for advancing clinical and commercial success in exosome and extracellular vesicle therapies. As the field progresses into later-stage trials, this meeting focuses on optimizing clinical strategies, scaling manufacturing, and strengthening analytical testing to meet evolving regulatory expectations. Bringing together industry pioneers, the summit fosters alignment across CMC, development, and regulatory pathways to de-risk platform growth and maximize investment potential. Join leaders in Boston to exchange insights, accelerate clinical progress, and drive the next generation of scalable, compliant exosome-based therapeutics toward approval and commercialization.
The 6th iPSC Drug Development Summit convenes senior biopharma leaders in Boston to address translational strategy, CMC, and scalable manufacturing for iPSC therapies, with insights from Astellas, BlueRock, Aspen, Vertex, and others advancing clinical programs.
